3544 results for «2117»
3544 results
Periprocedural management: TAVI
09 Feb 2025 – From PCR Tokyo Valves 2025
Want to elevate your expertise in TAVI periprocedural management? This session (in Japanese) is for you!
Discover the essential skills every team member needs for a smooth and successful TAVI procedure. Learn how radiologic technologists optimize imaging, how medical laboratory technologists provide critical real-time data, and how...
Imaging in TAVI
09 Feb 2025 – From PCR Tokyo Valves 2025
This session delves into the latest advancements in imaging for TAVI, covering a range of topics. Discover insights into clinical outcomes in patients with very low-gradient severe aortic stenosis after TAVI, the influence of TAVI valve differences on long-term outcomes in left ventricular mass index, the...
TAV-in-SAV - Part 2
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the second part of the TAV-in-SAV session, where you'll discover the reproducible BASILICA technique using an enface view, chimney stenting during TAV-in-SAV in a high coronary occlusion risk patient, urgent zero contrast TAV-in-SAV, a tale of a complication where you shouldn't BASILICA the new...
Mastering excellence: from valve selection to optimal outcomes with the Evolut TAVI system
07 Feb 2025 – From PCR Tokyo Valves 2025
Watch this expert-led session on the latest Evolut TAVI advancements, device selection for small annulus cases, and strategies for complex anatomies. Learn about redo-TAVI feasibility and key 1-year data from the SMART trial.
TAVI complications: hemolytic anemia, prosthetic valve endocarditis & stroke
08 Feb 2025 – From PCR Tokyo Valves 2025
Gain valuable insights into the management of complications associated with Transcatheter Aortic Valve Implantation (TAVI). Discover the latest evidence on hemolytic anemia, the predictive value of the hemoglobin to creatinine ratio, outcomes of transcarotid TAVI, a case study on prosthetic valve endocarditis, the role of diastolic...
How to optimise the patient outcomes - Key considerations for the small body population
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest strategies for optimizing outcomes in Asian and international patients with small body size. Through case presentations, surgical experiences, and the latest data on device performance, gain valuable insights into treating aortic stenosis more effectively. Discover how these advancements can enhance patient care and...
Mastering techniques from basic to complex - TEER for functional mitral regurgitation
07 Feb 2025 – From PCR Tokyo Valves 2025
Explore the complexities of functional mitral regurgitation (FMR) in this PCR Tokyo Valves 2025 session, where experts delve into key anatomical challenges and advanced TEER techniques. Learn why surgery remains the first-line treatment for atrial FMR, particularly when concomitant tricuspid regurgitation is present, and when radiofrequency...
TAVI complications cases - Part 1
08 Feb 2025 – From PCR Tokyo Valves 2025
Dive into the world of TAVI complications in this comprehensive session. Explore a range of challenging cases, including bailout implantation of an embolized self-expandable valve, ascending aortic dissection, coronary embolization, cardiac tamponade, and annular rupture. Gain insights into the management strategies and specialized techniques employed to...
TAVI access issues
08 Feb 2025 – From PCR Tokyo Valves 2025
Dive into the challenges and innovative solutions surrounding TAVI access issues in this comprehensive session. Discover a one-step operation of transcarotid TAVI and PDA occlusion, a bailout case of transfemoral TAVI through a severely bent and calcified aorta, the role of transcaval access in hostile peripheral...
TAV-in-SAV - Part 1
08 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the complex world of TAV-in-SAV (Transcatheter Aortic Valve-in-Surgical Aortic Valve) in this comprehensive session. Explore various case studies, including valve-in-valve TAVI in a patient with structural valve deterioration, a successful case of balloon-assisted BASILICA for TAV-in-TAV, and TAVI after valve sparing aortic replacement. Gain...
Understanding research: insights from a groundbreaking study
22 May 2025 – From EuroPCR 2025
Enhance your understanding of contemporary research in PCI versus CABG with this session. Learn foundational research principles, latest study findings, and how to translate evidence into clinical practice to improve patient communication and outcomes, bridging the gap between research and everyday cardiology care.
Electrosurgical techniques in transcatheter mitral valve replacement
22 May 2025 – From EuroPCR 2025
Delve into electrosurgical techniques in transcatheter mitral valve replacement. This session covers advanced methods including the tip-to-base lampoon technique, electrosurgical laceration of failed devices, left ventricular outflow tract obstruction management, combined septal ablation and valve-in-valve procedures, and management of severe aortic regurgitation post-laceration.
High-risk PCI in acute coronary syndrome
22 May 2025 – From EuroPCR 2025
Explore high-risk PCI strategies in acute coronary syndrome patients who are unsuitable for surgery. This session presents insights on Killip class influence, haemodynamic support with micro-axial flow pumps, disease progression patterns in complicated STEMI, and the prognostic value of QFR-guided functional SYNTAX scores in ACS management.
Calcified un-dilatable lesions in ACS: what should I do?
22 May 2025 – From EuroPCR 2025
Address the challenges of severely calcified undilatable lesions during acute coronary syndrome PCI. This session reviews the impact of coronary calcification on PCI strategy, highlights pitfalls in lesion preparation, and presents detailed case studies demonstrating effective treatment approaches.
Navigating complexity: TAVI in challenging anatomies
22 May 2025 – From EuroPCR 2025
Navigate the complexities of TAVI in challenging anatomies. This session reviews anatomical variations such as horizontal aorta, iliofemoral tortuosity, low coronary ostia, bicuspid valves, and annular eccentricity, alongside preprocedural imaging and risk stratification. It further evaluates device selection and procedural adaptations essential for successful TAVI in...
Which device for which patient: DES, BRS or DCB?
22 May 2025 – From EuroPCR 2025
This session provides comprehensive guidance on selecting the appropriate device—DES, BRS, or DCB—for individual patients and lesions. It examines patient and lesion characteristics, strengths and limitations of each device type, and regional considerations, illustrated by case presentations demonstrating practical device choice and resolution.
Innovative strategies for coronary interventions
22 May 2025 – From EuroPCR 2025
Explore innovative strategies in coronary interventions, including the EPIC26 sirolimus-eluting stent study, use of percutaneous ventricular assist devices in high-risk patients, the SCORE multicenter study on SeQuent SCB, DCB versus DES for ostial left circumflex lesions, and site-specific antithrombotic therapy outcomes from the DESyne BDS Plus...
Emerging indications for TAVI in 2025
22 May 2025 – From EuroPCR 2025
Prepare for emerging TAVI indications anticipated in 2025. This session reviews clinical cases including asymptomatic severe aortic stenosis, moderate aortic stenosis with heart failure, and severe aortic regurgitation. It discusses supporting evidence from clinical trials, evolving transcatheter technologies, and practical treatment approaches for these novel indications.
TAVI in women
22 May 2025 – From EuroPCR 2025
Focus on gender-specific considerations in TAVI with this session. Topics include timely management and referral disparities in women with severe aortic stenosis, early outcomes from the LANDMARK trial with latest-generation valves, insights from NAVULTRA comparing valve types, prosthesis-patient mismatch data, and gender differences in right ventricular...
Innovations in transcatheter aortic valve devices and techniques
22 May 2025 – From EuroPCR 2025
Explore the latest advancements in transcatheter aortic valve devices and innovative procedural techniques. This session presents initial clinical experiences with new self-expandable valves in small annuli, safety and performance data from the GENESIS-II study on the Hydra valve, and up to 12-month outcomes from the Valvosoft...
